Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,721
+$2,859 QoQ
Shares Held
1,685
+31.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#456
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $194,745 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (8.1% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,721 | 1,685 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,862 | 1,285 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,991 | 1,285 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,526 | 1,285 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,325 | 1,285 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,222 | 1,285 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,728 | 1,439 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $15,224 | 1,439 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $14,430 | 1,747 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,664 | 1,845 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $14,361 | 1,745 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $14,527 | 1,744 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $14,623 | 1,745 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $14,212 | 1,746 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $13,968 | 1,746 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $10,633 | 1,746 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||